BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garey KW, Begum K, Lancaster C, Gonzales-Luna A, Bui D, Mercier J, Seng Yue C, Ducharme MP, Hu M, Vince B, Silverman MH, Alam MJ, Kankam M. A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects. J Antimicrob Chemother 2020;75:3635-43. [PMID: 32892222 DOI: 10.1093/jac/dkaa364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kullar R, Tran MN, Goldstein EJC. Investigational Treatment Agents for Recurrent Clostridioides difficile Infection (rCDI). J Exp Pharmacol 2020;12:371-84. [PMID: 33116952 DOI: 10.2147/JEP.S242959] [Reference Citation Analysis]
2 Gonzales-Luna AJ, Carlson TJ, Garey KW. Antibiotic Therapies for Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc 2021;10:S52-7. [PMID: 34791393 DOI: 10.1093/jpids/piab059] [Reference Citation Analysis]
3 Garey KW, McPherson J, Dinh AQ, Hu C, Jo J, Wang W, Lancaster CK, Gonzales-Luna AJ, Loveall C, Begum K, Alam MJ, Silverman MH, Hanson B. Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial. Clin Infect Dis 2022:ciac096. [PMID: 35134880 DOI: 10.1093/cid/ciac096] [Reference Citation Analysis]
4 Hu C, Beyda ND, Garey KW. A Vancomycin HPLC Assay for Use in Gut Microbiome Research. Microbiol Spectr 2022;:e0168821. [PMID: 35536037 DOI: 10.1128/spectrum.01688-21] [Reference Citation Analysis]
5 Carlson TJ, Gonzales-Luna AJ, Garey KW. Recent developments in antimicrobial therapy for gastrointestinal infections. Curr Opin Gastroenterol 2021;37:30-6. [PMID: 33229860 DOI: 10.1097/MOG.0000000000000696] [Reference Citation Analysis]